TRIPLE HELIX BIOTECHNOLOGY LTD
Executive Summary
Triple Helix Biotechnology Ltd is a start-up biotech company with a stable but modest asset base and low liabilities. The company is currently loss-making with a significant drop in cash reserves over the past year, highlighting liquidity risk. Credit approval is conditional on continued monitoring of cash flow, profitability improvements, and management’s ability to secure additional funding to support ongoing operations.
View Full Analysis Report →- Legal registered address
- 12 New Fetter Lane London United Kingdom EC4A 1JP Copied!
Latest financial results as of 14 September 2025- Cash in bank
- £39.58k
- Current assets
- £59.75k
- Fixed assets
- £49.11k
- Current creditors
- £5.52k
- Shareholders funds
- £299.95k
View full financial accounts- Cash in bank
- £39.58k
- Current assets
- £59.75k
- Fixed assets
- £49.11k
- Current creditors
- £5.52k
- Shareholders funds
- £299.95k
- Company number
- 13749240 Copied!
Accounts
Latest annual accounts were to 30 November 2023
Next annual accounts are due by 30 November 2025
Company financial year end is on 30 November 2025
Confirmation statement
Latest confirmation statement statement dated 16 November 2024
Next statement due by 30 November 2025
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Latest company documents
Date | Description |
---|---|
18/11/2418 November 2024 | Confirmation statement made on 2024-11-16 with no updates |
12/11/2412 November 2024 | Change of details for Mr Zijie Wang as a person with significant control on 2024-09-15 |
12/11/2412 November 2024 | Director's details changed for Mr Zijie Wang on 2024-09-15 |
06/11/246 November 2024 | Change of details for Mr Da Lin as a person with significant control on 2021-11-24 |
25/10/2425 October 2024 | Total exemption full accounts made up to 2023-11-30 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company